Gauting, Germany

Felix Meissner

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Gauting, DE (2020 - 2022)
  • Berlin, DE (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Felix Meissner: Innovator in Medical and Analytical Technologies

Introduction

Felix Meissner is a notable inventor based in Gauting, Germany. He has made significant contributions to the fields of medical treatment and mass spectrometry. With a total of 3 patents, his work focuses on innovative methods that address critical health issues and enhance analytical techniques.

Latest Patents

Meissner's latest patents include groundbreaking inventions. One patent details methods for the treatment of infections, specifically inhibitors that target the interaction between HopQ and members of the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family. This invention also encompasses immunogenic compositions aimed at preventing or treating diseases associated with these interactions. Another significant patent involves the use of isobaric tags in mass spectrometry. This invention describes an isobaric label that fragments in a mass spectrometer at specific energy levels, improving the analysis of precursor ions.

Career Highlights

Throughout his career, Felix Meissner has worked with prestigious institutions. He has been associated with the Max Planck Society for the Advancement of Science and the Technical University of Munich. His work in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Meissner has collaborated with notable professionals in his field, including Matthias Mann and Tobias Kruse. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Felix Meissner's contributions to medical and analytical technologies highlight his role as an influential inventor. His patents reflect a commitment to innovation that addresses real-world challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…